Sedana Medical AB (publ), Interim Report, Q2, January-June 2017
Strong sales growth and initiated registration study for EuropeFinancial summary April-June · Net sales during the period increased to 9 549 (7 142) KSEK corresponding to an increase of 34% compared with the same period 2016. · Earnings before interest, taxes, depreciation and amortisation (EBITDA) were 673 (-702) KSEK. This corresponds to an EBITDA margin of 7,1%(-9,8%). · Earnings before interest and taxes (EBIT) were 408 (-781) KSEK which corresponds to an EBIT margin of 4,3% (-10,9%). · Cash flow from operations before change in working capital amounted to -1 461 (-